Correction: Neuroprotective effects of the pannexin-1 channel inhibitor: probenecid on spinal cord injury in rats

Authors:

Abstract
INTRODUCTION Spinal cord injury (SCI) is damage to the spinal cord caused by a sports accident, traffic accident, or fall from a height, which results in the loss of motor or sensory function, leading to a decrease in the quality of life and a heavy medical burden on the family and society (Gaojian et al., 2020). The treatment of SCI has been a challenge for the medical community because of the poor regenerative capacity of neurons after SCI and the rapid appearance of glial scarring, which makes it difficult to repair and reconstruct the spinal cord tissue and function (Wang et al., 2019). Therefore, it is significant to explore effective treatments for SCI to improve patients' quality of life and reduce the medical burden for families and society. Spinal cord injury contains two phases, the primary phase and the secondary phase (the main phase). The mechanisms of secondary injury after SCI are complex and include neuroinflammatory response, ischemia and hypoxia, lipid peroxidation, apoptosis, etc. (Wu and Xu, 2016). Qi et al. Neuroprotective Effects on SCI Among them, the neuroinflammatory response has been regarded as an important factor in the pathological process leading to secondary injury (Scholtes et al., 2012). The pathophysiological processes of secondary injury, such as apoptosis, edema, glial scarring, and inflammation in the injured tissue, severely impact the conduction function of nerves in the corresponding spinal cord segments. The inflammatory response during SCI includes local immune cell activation of the injury, the infiltration of peripheral immune cells, and the production of proinflammatory factors, which ultimately lead to spinal cord dysfunction (Sun et al., 2016). Effective and early use of anti-inflammatory drugs is of considerable importance to improve the local immune microenvironment and promote neuronal regeneration and recovery of spinal cord function. Probenecid, a sulfonamide derivative approved for use in 1951, has been used to treat gout and its adverse effects, and pharmacokinetics have been intensively studied (Baranova et al., 2004; Papadopoulos and Verkman, 2008). One study found that oxidative stress in nerve cells can be effectively inhibited by probenecid (Cheng and Kim, 2020). Another study showed that probenecid also acts as a pannexin-1 channel inhibitor and may inhibit the activation of inflammasomes (Silverman et al., 2009). Inflammasomes are multiprotein complexes that mainly consist of intracellular pattern recognition receptors (PRRs), apoptosis-associated speck-like protein containing a card (ASC), and pro-caspase-1 (Christgen et al., 2020). The pannexin-1 channel presents mainly in the brain, spinal cord, and thyroid gland (Bruzzone et al., 2003). It has a great effect on the activation of inflammasomes. In a study of a rat brain model of cognitive impairment, probenecid was found to inhibit the activation of nucleotide-binding oligomerization domain receptor pyrindomain-containing 1 (NLRP1) inflammasomes and reduce the activation of caspase-1, which in turn reduced the degree of cognitive impairment in rats (Mawhinney et al., 2011). Several studies have reported that probenecid can also reduce neuropathic pain in the spinal cord (Pineda-Farias et al., 2013; Bravo et al., 2014). These reports suggest that during the injury process of the central nervous system (CNS), probenecid has a neuroprotective and restorative effect on CNS injury, SCI has a similar process; however, it has not been reported whether this drug is useful for the treatment of SCI. In the immune microenvironment at the site of SCI, there are generally M1 and M2 two phenotypes of macrophages. They appear in all stages from SCI to recovery, especially playing an indispensable part in the secondary inflammatory response of SCI (Martinez et al., 2008; Milich et al., 2019; Zhang et al., 2020). M1 cells can produce high levels of proinflammatory cytokines, such as secreting proinflammatory factors, like tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β), which induce the production of inflammatory cascade responses. M2 cells can secrete anti-inflammatory factors like IL-4, IL-10, and other factors, which reduce the inflammatory response and promote wound healing (Gensel and Zhang, 2015). Whether probenecid affects the polarization of microglia/macrophages to exert neuroprotective effects on SCI is an important research value to explore new mechanisms of SCI pathology and find new targets for treatment. MATERIALS AND METHODS Experimental Animals In this experiment, a total of 98 SPF-grade women standard deviation (SD) rats (weight, 200–220 g; age, 8 weeks old) were used. All these rats were provided by Jinan Pengyue Experimental Animal Breeding Co., Ltd., Jinan, China, under license No. SCXK (Lu) 2019-0003. All surgical operations and postoperative care of SD rats during the experiment were approved by the Committee on the Laboratory Animal Care and Use of Bengbu Medical College. Experimental Methods Preparation of Spinal Cord Injury Models in Adult Rats Before performing the test, SD rats were housed in an environment with the appropriate humidity and temperature and given adequate feed and water for 5–7 days. Before surgery, the required surgical instruments were soaked in 75% alcohol (Shangdong Lierkang Co., Dezhou, China) for 30 min and sterilized with UV light for 30 min. During the operation, firstly, SD rats were anesthetized with 10% trichloroacetaldehyde intraperitoneally, then the rat hair around the T9 vertebral plate on the back of the rats was removed, the skin, fascia, and muscles of the corresponding part of T9 were cut open with a scalpel (Shanghai Medical Equipment Co., Shanghai, China), the T9 spinous process was removed with a bite forceps, and the vertebral plate was bitten along the interspinal foramen between T9 and T10 to fully expose the spinal cord, forming a circular opening of about 2.5 mm in diameter....